Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

866 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
Halcox JP, Banegas JR, Roy C, Dallongeville J, De Backer G, Guallar E, Perk J, Hajage D, Henriksson KM, Borghi C. Halcox JP, et al. Among authors: borghi c. BMC Cardiovasc Disord. 2017 Jun 17;17(1):160. doi: 10.1186/s12872-017-0591-5. BMC Cardiovasc Disord. 2017. PMID: 28623902 Free PMC article.
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA).
Rodríguez-Artalejo F, Guallar E, Borghi C, Dallongeville J, De Backer G, Halcox JP, Hernández-Vecino R, Jiménez FJ, Massó-González EL, Perk J, Steg PG, Banegas JR; EURIKA Investigators. Rodríguez-Artalejo F, et al. Among authors: borghi c. BMC Public Health. 2010 Jun 30;10:382. doi: 10.1186/1471-2458-10-382. BMC Public Health. 2010. PMID: 20591142 Free PMC article.
Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study.
Cimminiello C, Borghi C, Kownator S, Wautrecht JC, Carvounis CP, Kranendonk SE, Kindler B, Mangrella M; PANDORA Study Investigators. Cimminiello C, et al. Among authors: borghi c. BMC Cardiovasc Disord. 2010 Aug 5;10:35. doi: 10.1186/1471-2261-10-35. BMC Cardiovasc Disord. 2010. PMID: 20687927 Free PMC article. Clinical Trial.
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.
Banegas JR, López-García E, Dallongeville J, Guallar E, Halcox JP, Borghi C, Massó-González EL, Jiménez FJ, Perk J, Steg PG, De Backer G, Rodríguez-Artalejo F. Banegas JR, et al. Among authors: borghi c. Eur Heart J. 2011 Sep;32(17):2143-52. doi: 10.1093/eurheartj/ehr080. Epub 2011 Apr 6. Eur Heart J. 2011. PMID: 21471134 Free PMC article. Clinical Trial.
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study.
Guallar E, Banegas JR, Blasco-Colmenares E, Jiménez FJ, Dallongeville J, Halcox JP, Borghi C, Massó-González EL, Tafalla M, Perk J, De Backer G, Steg PG, Rodríguez-Artalejo F. Guallar E, et al. Among authors: borghi c. BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704. BMC Public Health. 2011. PMID: 21923932 Free PMC article.
Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk: Italian results from the PANDORA study Data from PANDORA (Prevalence of peripheral Arterial disease in subjects with moderate CVD risk, with No overt vascular Diseases nor Diabetes mellitus).
Sanna G, Alesso D, Mediati M, Cimminiello C, Borghi C, Fazzari AL, Mangrella M; PANDORA study investigators. Sanna G, et al. Among authors: borghi c. BMC Cardiovasc Disord. 2011 Oct 7;11:59. doi: 10.1186/1471-2261-11-59. BMC Cardiovasc Disord. 2011. PMID: 21981988 Free PMC article. Clinical Trial.
Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study.
Banegas JR, López-García E, Dallongeville J, Guallar E, Halcox JP, Borghi C, Massó-González EL, Sazova O, Perk J, Steg PG, De Backer G, Rodríguez-Artalejo F. Banegas JR, et al. Among authors: borghi c. Int J Cardiol. 2013 Jun 5;166(1):210-4. doi: 10.1016/j.ijcard.2011.10.094. Epub 2011 Nov 5. Int J Cardiol. 2013. PMID: 22056474 Clinical Trial.
C-reactive protein levels in patients at cardiovascular risk: EURIKA study.
Halcox JP, Roy C, Tubach F, Banegas JR, Dallongeville J, De Backer G, Guallar E, Sazova O, Medina J, Perk J, Steg PG, Rodríguez-Artalejo F, Borghi C. Halcox JP, et al. Among authors: borghi c. BMC Cardiovasc Disord. 2014 Feb 24;14:25. doi: 10.1186/1471-2261-14-25. BMC Cardiovasc Disord. 2014. PMID: 24564178 Free PMC article.
Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe.
Halcox JP, Tubach F, Lopez-Garcia E, De Backer G, Borghi C, Dallongeville J, Guallar E, Medina J, Perk J, Sazova O, Sweet S, Roy C, Banegas JR, Rodriguez-Artalejo F. Halcox JP, et al. Among authors: borghi c. PLoS One. 2015 Feb 18;10(2):e0115270. doi: 10.1371/journal.pone.0115270. eCollection 2015. PLoS One. 2015. PMID: 25692692 Free PMC article.
866 results